A citation-based method for searching scientific literature

M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
Times Cited: 92







List of co-cited articles
651 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
434
43

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
604
39

Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
184
35



Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
145
29

Interest in genetic testing among first-degree relatives of breast cancer patients.
C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
263
29

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
28

Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
127
27

Attitudes towards cancer predictive testing and transmission of information to the family.
C Julian-Reynier, F Eisinger, P Vennin, F Chabal, Y Aurran, C Noguès, Y J Bignon, M Machelard-Roumagnac, C Maugard-Louboutin, D Serin,[...]. J Med Genet 1996
100
22

Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
128
19

Awareness and attitudes concerning BRCA gene testing.
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
48
37

The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
139
18


Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
92
18

Attitudes to genetic testing for breast cancer susceptibility in women at increased risk developing hereditary breast cancer.
B Meiser, P Butow, A Barratt, G Suthers, M Smith, A Colley, E Thompson, K Tucker. J Med Genet 2000
46
34

Factors associated with decisions about clinical BRCA1/2 testing.
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
101
17



Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
15

Genetic testing for cancer risk: a population survey on attitudes and intention.
Cornelia M Ulrich, Alan R Kristal, Emily White, Julie R Hunt, Sharon J Durfy, John D Potter. Community Genet 1998
50
28

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
276
15

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
225
14

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
14

Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
163
13

Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
106
13

Why do women attend familial breast cancer clinics?
K Brain, J Gray, P Norman, E Parsons, A Clarke, C Rogers, R Mansel, P Harper. J Med Genet 2000
85
14

Racial differences in testing motivation and psychological distress following pretest education for BRCA1 gene testing.
C Lerman, C Hughes, J L Benkendorf, B Biesecker, J Kerner, J Willison, N Eads, D Hadley, J Lynch. Cancer Epidemiol Biomarkers Prev 1999
116
13

Hereditary cancer risk notification and testing: how interested is the general population?
M A Andrykowski, R Lightner, J L Studts, R K Munn. J Clin Oncol 1997
59
20

Perception of breast cancer risk among women in breast center and primary care settings: correlation with age and family history of breast cancer.
B L Smith, M A Gadd, C Lawler, D J MacDonald, S C Grudberg, F S Chi, K Carlson, A Comegno, W W Souba. Surgery 1996
65
16

BRCA1 and BRCA2: from molecular genetics to clinical medicine.
M A Blackwood, B L Weber. J Clin Oncol 1998
133
11



Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
63
17


Attitudes toward colon cancer gene testing: factors predicting test uptake.
A M Codori, G M Petersen, D L Miglioretti, E K Larkin, M T Bushey, C Young, J D Brensinger, K Johnson, J A Bacon, S V Booker. Cancer Epidemiol Biomarkers Prev 1999
122
10



A region of mouse chromosome 16 is syntenic to the DiGeorge, velocardiofacial syndrome minimal critical region.
N Galili, H S Baldwin, J Lund, R Reeves, W Gong, Z Wang, B A Roe, B S Emanuel, S Nayak, C Mickanin,[...]. Genome Res 1997
73
13

Nager acrofacial dysostosis.
M T McDonald, J L Gorski. J Med Genet 1993
50
20

Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study.
A K Ryan, J A Goodship, D I Wilson, N Philip, A Levy, H Seidel, S Schuffenhauer, H Oechsler, B Belohradsky, M Prieur,[...]. J Med Genet 1997
833
10

CBFA1 mutation analysis and functional correlation with phenotypic variability in cleidocranial dysplasia.
G Zhou, Y Chen, L Zhou, K Thirunavukkarasu, J Hecht, D Chitayat, B D Gelb, S Pirinen, S A Berry, C R Greenberg,[...]. Hum Mol Genet 1999
173
10




Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss.
P M Kelley, D J Harris, B C Comer, J W Askew, T Fowler, S D Smith, W J Kimberling. Am J Hum Genet 1998
385
10

Congenital macular colobomas and short-limb skeletal dysplasia.
R D Smith, R M Fineman, D O Sillence, P D Lester, G W Nixon, D L Rimoin, R S Lachman. Am J Med Genet 1980
15
66

Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system.
A Kuklin, K Munson, D Gjerde, R Haefele, P Taylor. Genet Test 1997
131
10

Associated malformations and chromosomal defects in congenital diaphragmatic hernia.
R Bollmann, K Kalache, H Mau, R Chaoui, C Tennstedt. Fetal Diagn Ther 1995
81
12

Associated anomalies in individuals with polydactyly.
E E Castilla, R Lugarinho, M da Graça Dutra, L J Salgado. Am J Med Genet 1998
47
21


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.